LGALS9 and primary cutaneous T-cell non-Hodgkin lymphoma: Galectin-9 is increased in several hematologic neoplasia, including chronic lymphocytic leukemia [64], cutaneous T cell lymphoma, and acute myeloid leukemia (AML) [65].